HuGE Literature Finder
Records
1
-
30
| Novel variant in glycophorin c gene protects against ribavirin-induced anemia during chronic hepatitis C treatment. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2021 Sep 143 112195. Lin Jennifer J, Loucks Catrina M, Trueman Jessica N, Drögemöller Britt I, Wright Galen E B, Yoshida Eric M, Ford Jo-Ann, Lee Samuel S, Kim Richard B, Al-Judaibi Bandar, Schwarz Ute I, Ramji Alnoor, Tam Edward, Ross Colin J, Carleton Bruce |
| Association of genetic variants in TPMT, ITPA, and NUDT15 with azathioprine-induced myelosuppression in southwest china patients with autoimmune hepatitis. Scientific reports 2021 Apr 11 (1): 7984. Miao Qiang, Yan Lin, Zhou Yanhong, Li Yi, Zou Yuangao, Wang Lanlan, Bai Yangjuan, Zhang Junlo |
| Absence of interferon-? 4 enhances spontaneous clearance of acute hepatitis C virus genotypes 1-3 infection. Scandinavian journal of gastroenterology 2021 5 56 (7): 855-861. Waldenström Jesper, Kåberg Martin, Alanko Blomé Marianne, Widell Anders, Björkman Per, Nilsson Staffan, Hammarberg Anders, Weiland Ola, Nyström Kristina, Lagging Mart |
| [Association of ITPA gene variants and ribavirin-related anemia in Han Chinese with chronic hepatitis C genotype 1 infection]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology 2018 Jun 26 (6): 463-465. Shen T T, Zheng C, Xie L F, Xu L L, Zhang |
| A facile PCR-RFLP method for genotyping of ITPA rs1127354 and rs7270101 polymorphisms. Journal of clinical laboratory analysis 2018 4 32 (7): e22440. Alavian Seyed Ehsan, Sharafi Heidar, Shirmast Paniz, Alavian Seyed Moayed, Behnava Bita, Pouryasin Mohammad, Keshvari Maryam, Pouryasin A |
| Reduced ITPase activity and favorable IL28B genetic variant protect against ribavirin-induced anemia in interferon-free regimens. PloS one 2018 13 (5): e0198296. Vasanthakumar Aparna, Davis Justin W, Abunimeh Manal, Söderholm Jonas, Zha Jiuhong, Dumas Emily O, Cohen Daniel E, Waring Jeffrey F, Lagging Mart |
| The role of ITPA and ribavirin transporter genes polymorphisms in prediction of ribavirin-induced anaemia in chronic hepatitis C Egyptian patients. Clinical and experimental pharmacology & physiology 2017 Sep 44 (9): 965-968. El Desoky Ehab S, Abdelhafez Alaa T, Cusato Jessica, Kamel Sherif I, Hussein Abeer Mr, De Nicolo Amedeo, Di Perri Giovanni, D'Avolio Anton |
| The relationship between ITPA rs1127354 polymorphisms and efficacy of antiviral treatment in Northeast Chinese CHC patients. Medicine 2017 Jul 96 (29): e7554. Liu Zhenhua, Wang Song, Qi Wenqian, Wang Xu, Sun Derong, Wang Hongguang, Zhang Yonggui, Li Zhongxie, Zhu Liying, Zhao Ping, Guo Honghua, Zhou Changyu, Wang Jiangb |
| ITPA gene polymorphism (94C>A) effects on ribavirin-induced anemia during therapy in Egyptian patients with chronic hepatitis C. Journal of medical virology 2017 May . Raziky Maissa El, Zayed Naglaa Ali, Baki Amin Abdel, Mansour Shimaa Afify, Shahin Rasha Mohamad Hos |
| High Prevalence of ITPA Alleles Associated with Ribavirin-Induced Hemolytic Anemia Among Mexican Population. Annals of hepatology 2017 Feb 16 (2): 221-229. Gonzalez-Aldaco Karina, Rebello Pinho João, Panduro Arturo, Martinez-Lopez Erika, Gleyzer Ketti, Fierro Nora, Roman Son |
| Impact of ITPA gene polymorphisms on the risk of ribavirin-induced haemolytic anaemia using interferon-free antivirals for chronic hepatitis C. Antiviral therapy 2017 Feb . Esposito Isabella, Benítez-Gutiérrez Laura, Treviño Ana, Arias Ana, Citores Maria Jesus, Requena Silvia, Soriano Vicente, Cuervas-Mons Valentín, de Mendoza Carm |
| Correlation between polymorphism in the inosine triphosphatase and the reductions in hemoglobin concentration and ribavirin dose during sofosbuvir and ribavirin therapy. Journal of gastroenterology and hepatology 2017 Jan . Kozuka Ritsuzo, Hai Hoang, Teranishi Yuga, Motoyama Hiroyuki, Kawamura Etsushi, Hagihara Atsushi, Uchida-Kobayashi Sawako, Morikawa Hiroyasu, Enomoto Masaru, Murakami Yoshiki, Kawada Norifumi, Tamori Akihi |
| ITPA gene variation and ribavirin-induced anemia in patients with genotype 2 chronic hepatitis C treated with sofosbuvir plus ribavirin. Hepatology research : the official journal of the Japan Society of Hepatology 2017 Jan . Murakawa Miyako, Asahina Yasuhiro, Nagata Hiroko, Nakagawa Mina, Kakinuma Sei, Nitta Sayuri, Kawai-Kitahata Fukiko, Otani Satoshi, Kaneko Shun, Miyoshi Masato, Tsunoda Tomoyuki, Asano Yu, Sato Ayako, Itsui Yasuhiro, Azuma Seishin, Nouchi Toshihiko, Furumoto Yohei, Asano Tooru, Chuganji Yoshimichi, Tohda Shuji, Watanabe Mamo |
| Real world experience with pegylated interferon and ribavirin in hepatitis C genotype 1 population with favourable IL28B polymorphism. Gastroenterology report 2017 8 5 (3): 208-212. Ekstrom Victoria, Kumar Rajneesh, Zhao Yi, Yee Mei Ling, Sung Cynthia, Toh Dorothy, Loh Poh Yen, Tan Jessica, Teo Eng Kiong, Chow Wan Che |
| ITPA polymorphism effects on decrease of hemoglobin during sofosbuvir and ribavirin combination treatment for chronic hepatitis C. Journal of gastroenterology 2016 Nov . Morio Kei, Imamura Michio, Kawakami Yoshiiku, Nakahara Takashi, Nagaoki Yuko, Kawaoka Tomokazu, Tsuge Masataka, Hiramatsu Akira, Aikata Hiroshi, Hayes Clair Nelson, Makokha Grace Naswa, Ochi Hidenori, Amano Hajime, Arataki Keiko, Moriya Takashi, Ito Hiroyuki, Tsuji Keiji, Kohno Hiroshi, Waki Koji, Tamura Toru, Nakamura Toshio, Chayama Kazuaki, |
| Estimated glomerular filtration rate but not solute carrier polymorphisms influences anemia in HIV-hepatitis C virus coinfected patients treated with boceprevir or telaprevir-based therapy. AIDS (London, England) 2016 May . Kheloufi Farid, Bellissant Eric, Cotte Laurent, Poizot-Martin Isabelle, Quaranta Sylvie, Garraffo Rodolphe, Barrail-Tran Aurélie, Renault Alain, Fournier Isabelle, Lacarelle Bruno, Bourlière Marc, Molina Jean-Michel, Solas Caroline, |
| Impact of ribavirin dosage in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin combination therapy. Journal of medical virology 2016 Mar . Tahata Yuki, Hiramatsu Naoki, Oze Tsugiko, Urabe Ayako, Morishita Naoki, Yamada Ryoko, Yakushijin Takayuki, Hosui Atsushi, Oshita Masahide, Kaneko Akira, Hagiwara Hideki, Mita Eiji, Ito Toshifumi, Yamada Yukinori, Inada Masami, Katayama Kazuhiro, Tamura Shinji, Imai Yasuharu, Hikita Hayato, Sakamori Ryotaro, Yoshida Yuichi, Tatsumi Tomohide, Hayashi Norio, Takehara Tets |
| Effects of ITPA polymorphism on decrease of hemoglobin during simeprevir, peg-interferon, and ribavirin combination treatment for chronic hepatitis C. Hepatology research : the official journal of the Japan Society of Hepatology 2016 Feb . Morio Kei, Imamura Michio, Kawakami Yoshiiku, Morio Reona, Hatooka Masahiro, Kan Hiromi, Fujino Hatsue, Fukuhara Takayuki, Kobayashi Tomoki, Masaki Keiichi, Ono Atsushi, Nakahara Takashi, Urabe Ayako, Yokoyama Satoe, Nagaoki Yuko, Kawaoka Tomokazu, Hiraga Nobuhiko, Tsuge Masataka, Hiramatsu Akira, Hayes C Nelson, Aikata Hiroshi, Ochi Hidenori, Chayama Kazuaki, |
| Role of ITPA gene polymorphism in ribavirin-induced anemia and thrombocytopenia in Egyptian patients with chronic hepatitis C. Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology 2016 Feb . Nemr Nader, Kishk Rania, Mandour Moham |
| The ITPA and C20orf194 Polymorphisms and Hematological Changes During Treatment With Pegylated-Interferon Plus Ribavirin in Patients With Chronic Hepatitis C. Hepatitis monthly 2016 Feb 16 (2): e35278. Pouryasin Mohammad, Keshvari Maryam, Sharafi Heidar, Alavian Seyed Moayed, Behnava Bita, Alavian Seyed Ehsan, Pouryasin A |
| Rapidity and Severity of Hemoglobin Decreasing Associated with Erythrocyte Inosine Triphosphatase Activity and ATP Concentration during Chronic Hepatitis C Treatment. Biological & pharmaceutical bulletin 2016 39 (4): 615-9. Tanaka Yoichi, Tamura Yumi, Yokomori Hiroaki, Komiyama Taka |
| Does Epoetin Beta Still Have a Place in Peginterferon Alpha-2a Plus Ribavirin Treatment Strategies for Chronic Hepatitis C? Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research 2015 Dec . Veillon Pascal, Fouchard-Hubert Isabelle, Larrey Dominique, Dao Manh Thông, D'alteroche Louis, Boyer-Darrigand Nathalie, Picard Nicolas, Le Guillou-Guillemette Hélène, Saulnier Patrick, Ducancelle Alexandra, Loustaud-Ratti Véronique, Lunel-Fabiani Françoi |
| Predictive factors for 24 weeks sustained virologic response (SVR24) and viral relapse in patients treated with simeprevir plus peginterferon and ribavirin. Hepatology international 2015 Aug . Nakayama Masahiko, Kobayashi Hisanori, Fukushima Koji, Ishido Miwako, Komada Yuji, Yoshizawa Kazuta |
| Roles of ITPA and IL28B genotypes in chronic Hepatitis C patients treated with peginterferon plus ribavirin in Tunisian population. Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 2015 Aug 69 184-9. Sghaier Ikram, Mouelhi Leila, Gazouani Ezzedine, Morel Virginie, Besma Yacoubi Loueslati, Brochot Etien |
| The impact of an inosine triphosphate pyrophosphatase genotype on bilirubin increase in chronic hepatitis C patients treated with simeprevir, pegylated interferon plus ribavirin. Journal of gastroenterology 2015 Jul . Tahata Yuki, Hiramatsu Naoki, Oze Tsugiko, Morishita Naoki, Harada Naoki, Yamada Ryoko, Yakushijin Takayuki, Mita Eiji, Hagiwara Hideki, Yamada Yukinori, Ito Toshifumi, Hijioka Taizo, Inada Masami, Katayama Kazuhiro, Tamura Shinji, Yoshihara Harumasa, Inoue Atsuo, Imai Yasuharu, Irishio Keiko, Kato Michio, Hikita Hayato, Sakamori Ryotaro, Miyagi Takuya, Yoshida Yuichi, Tatsumi Tomohide, Hamasaki Toshimitsu, Hayashi Norio, Takehara Tets |
| Role of ITPA and IL28B variants in the management of chronic hepatitis C treatment. Le infezioni in medicina : rivista periodica di eziologia, epidemiologia, diagnostica, clinica e terapia delle patologie infettive 2015 Jun 23 (2): 134-9. Zampino Rosa, Alessio Loredana, Marrone Aldo, Stanzione Maria, Boemio Adriana, Grandone Anna, Minichini Carmine, Pisaturo Mariantonietta, Starace Mario, Adinolfi Luigi Elio, Sagnelli Evangelista, Coppola Nico |
| Impact of IL28B, APOH and ITPA Polymorphisms on Efficacy and Safety of TVR- or BOC-Based Triple Therapy in Treatment-Experienced HCV-1 Patients with Compensated Cirrhosis from the ANRS CO20-CUPIC Study. PloS one 2015 10 (12): e0145105. About Frédégonde, Oudot-Mellakh Tiphaine, Niay Jonathan, Rabiéga Pascaline, Pedergnana Vincent, Duffy Darragh, Sultanik Philippe, Cagnot Carole, Carrat Fabrice, Marcellin Patrick, Zoulim Fabien, Larrey Dominique, Hézode Christophe, Fontaine Hélène, Bronowicki Jean-Pierre, Pol Stanislas, Albert Matthew L, Theodorou Ioannis, Cobat Aurélie, Abel Laurent, |
| ITPA and SLC29A1 Genotyping for the Prediction of Ribavirin Dose Reduction in Anti-HCV Triple Therapy with Protease Inhibitors. Pharmacology 2015 96 (3-4): 163-6. Lombardi Andrea, Landonio Simona, Magni Carlo, Cheli Stefania, Mazzali Cristina, Mondelli Mario U, Rizzardini Giuliano, Clementi Emilio, Falvella Felicia Stefan |
| ITPA Polymorphisms Are Associated with Hematological Side Effects during Antiviral Therapy for Chronic HCV Infection. PloS one 2015 10 (10): e0139317. Maan Raoel, van der Meer Adriaan J, Brouwer Willem Pieter, Plompen Elisabeth P C, Sonneveld Milan J, Roomer Robert, van der Eijk Annemiek A, Groothuismink Zwier M A, Hansen Bettina E, Veldt Bart J, Janssen Harry L A, Boonstra Andre, de Knegt Robert |
| ITPA Genotypes Predict Anemia but Do Not Affect Virological Response with Interferon-Free Faldaprevir, Deleobuvir, and Ribavirin for HCV Infection. PloS one 0 10 (12): e0144004. Asselah Tarik, Zeuzem Stefan, Soriano Vicente, Bronowicki Jean-Pierre, Lohse Ansgar W, Müllhaupt Beat, Schuchmann Marcus, Bourlière Marc, Buti Maria, Roberts Stuart K, Gane Edward J, Stern Jerry O, Voss Florian, Baum Patrick, Gallivan John-Paul, Böcher Wulf O, Mensa Federico |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 22, 2023
- Content source: